IMNM
Immunome·NASDAQ
--
--(--)
--
--(--)
IMNM fundamentals
Immunome (IMNM) released its earnings on Aug 6, 2025: revenue was 4.02M (YoY +69.62%), beat estimates; EPS was -0.5 (YoY +16.67%), met estimates.
Revenue / YoY
4.02M
+69.62%
EPS / YoY
-0.5
+16.67%
Report date
Aug 6, 2025
Earnings Call
9:30 AM on Aug 6, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Immunome (IMNM) key financial stats and ratios, covering profitability, financial health, and leverage.
Immunome (IMNM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immunome (IMNM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immunome (IMNM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immunome (IMNM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immunome (IMNM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Immunome's earnings call?What is Immunome's gross profit margin?Did Immunome beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Immunome year over year?What were the key takeaways from Immunome’s earnings call?What is Immunome's latest dividend and current dividend yield?What does Immunome do and what are its main business segments?What is the market's earnings forecast for Immunome next quarter?
